1200 Participants Needed

Mobile Technology for Safer Automobile Driving

MZ
Overseen ByMotao Zhu, MD,MS,PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Motao Zhu
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to test whether a cellphone-blocking app and a special driving mode can improve driving behavior. It focuses on drivers aged 18-24 who often use their phones while driving. Participants will either have the app active, use driving mode, or be in a control group with the app installed but inactive. Ideal candidates are young adults in the Greater Columbus area who frequently drive and admit to using their phone while driving at least once a week. As an unphased trial, participants can contribute to innovative research that may enhance road safety for young drivers.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this mobile technology is safe for drivers aged 18-24 years?

Research has shown that using apps to block cellphone use and driving mode features on smartphones can reduce distractions while driving. These tools improve safety by limiting phone use when drivers are behind the wheel.

For the Commercial Cellphone-Blocking App, similar apps like Hiya and Truecaller are popular for blocking unwanted calls. These apps are safe because they manage phone use without affecting the phone's overall function. They work well with smartphones, allowing emergency calls and hands-free options.

Regarding Driving Mode, research highlights that distracted driving is a major cause of accidents. Driving modes on phones aim to prevent these distractions by limiting phone use while driving. Many smartphones have these features built-in and users report no significant issues. They are designed to be easy to use and enhance safety without causing inconvenience.

In summary, both the cellphone-blocking app and driving mode are considered safe and effective for reducing driving distractions. They help keep drivers focused on the road, which is crucial for preventing accidents.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative ways to enhance road safety using mobile technology. The trial examines a commercial cellphone-blocking app and a driving mode that aim to reduce distracted driving. Unlike many existing options that rely on driver discipline, these interventions actively restrict handheld phone use while driving, potentially minimizing distractions. Additionally, the app allows for emergency calls and includes a feature that lets passengers use the phone, offering a balance between safety and functionality. By testing these technologies, researchers hope to find effective solutions to make driving safer by reducing phone-related distractions.

What evidence suggests that this trial's interventions could be effective for improving driving behavior?

Research shows that apps designed to block cellphone use can help reduce distractions while driving. These apps allow important calls, such as those in emergencies, but block other phone functions that can divert attention from the road. Studies on these apps indicate they can significantly decrease distractions, helping drivers stay focused.

In this trial, participants will be divided into groups to test the effectiveness of these technologies. One group will use a commercial cellphone-blocking app that blocks handheld cellphone use while driving but allows emergency calls and phone use after pressing the passenger button. Another group will use the driving mode, which either blocks handheld phone use or facilitates hands-free use, depending on the smartphone type and service provider. A control group will have the commercial cellphone-blocking app installed, but it will remain inactive.

A review of real-world driving studies found that giving drivers feedback and using certain app features can improve driving habits. These features can either block phone use or allow hands-free functions, depending on the phone and service provider. Together, these tools aim to make driving safer for young drivers by reducing distractions and promoting responsible phone use.12467

Who Is on the Research Team?

MZ

Motao Zhu

Principal Investigator

Abigail Wexner Research Institute at Nationwide Children's Hospital

Are You a Good Fit for This Trial?

This trial is for young adults aged 18-24 in the Columbus, Ohio area who have a full driver's license and own a smartphone with active service. Participants must drive regularly, have their own insured vehicle, and not be using any other driving study apps or devices. They should also admit to using their phone while driving at least once a week.

Inclusion Criteria

I use my phone for calls or texts while driving at least once a week.
I am willing to follow the study's requirements and accept random assignment.
Must not be enrolled in another driving-related research study during the study period
See 7 more

Exclusion Criteria

Current users of a cellphone-blocking app or driving mode who do not agree to uninstall/de-activate the app for the duration of participation in the study
I am under 18 years old.
I drive 2 days a week or less.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants are randomized into one of three study groups to evaluate the effects of cellphone-blocking apps and driving mode interventions on driving behavior

5 months

Follow-up

Participants are monitored for safety and effectiveness after the intervention period

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Commercial Cellphone-Blocking App
  • Driving Mode
Trial Overview The study is testing if a commercial cellphone-blocking app or activating a 'driving mode' can change how often young drivers use their phones while driving. Drivers will be randomly assigned to one of these interventions to see which is more effective.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Driving ModeExperimental Treatment1 Intervention
Group II: Commercial Cellphone-Blocking AppExperimental Treatment1 Intervention
Group III: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Motao Zhu

Lead Sponsor

Trials
2
Recruited
1,400+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Ohio State University

Collaborator

Trials
891
Recruited
2,659,000+

University of Iowa

Collaborator

Trials
486
Recruited
934,000+

Published Research Related to This Trial

Hand-held cellular phone use by drivers in Michigan more than doubled from 2.7% in 2001 to 5.8% in 2005, indicating a significant increase in this risky behavior over a 4-year period.
If the trend continues, it is predicted that by 2010, approximately 8.6% of drivers will be using hand-held phones while driving, which could lead to increased traffic safety concerns and the need for effective interventions.
Driver hand-held cellular phone use: a four-year analysis.Eby, DW., Vivoda, JM., St Louis, RM.[2018]
A study involving 1139 participants from a larger trial found that 96% of respondents supported the use of SMS for monitoring vaccine safety after immunization, indicating a strong public acceptance of this method.
While most participants favored SMS surveillance, 62% believed that consent should be obtained beforehand, highlighting a need for addressing privacy concerns and understanding demographic factors that may affect compliance.
Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial.Gold, MS., Lincoln, G., Bednarz, J., et al.[2021]
In a study involving 153 employees, 42% participated in testing an app designed for reporting adverse events following immunization (AEFI), with 63% of users rating the experience positively, indicating good acceptance of the app-based technology.
Concerns about data protection were the main reason for declining participation, suggesting that improving data security measures could enhance the acceptability and effectiveness of app-based AEFI reporting systems.
User preferences for a mobile application to report adverse events following vaccination.Nguyen, MTH., Ott, JJ., Caputo, M., et al.[2020]

Citations

Hiya: Spam Blocker & Caller ID - Apps on Google PlayDesigned to shield you from spam, Hiya is not just a call blocker; it's a comprehensive solution for smarter, safer, and stress-free communication.
TOP 7 Call Blocker for Android and iPhone [Tested]To block unknown numbers, Phone Call Blocker, Should I Answer, or Call Blacklist deserve a try. Among them, Call Control and Truecaller do both well.
Truecaller: Spam Call Blocker - Apps on Google PlayTruecaller's Caller ID & Blocker instantly identifies who's calling, empowering you to effortlessly block spam, scam, and unwanted calls.
Block Spam Calls with TruecallerExperience seamless spam blocking with Truecaller. The app effortlessly identifies robocalls, telemarketers, scams, fraud, and harassment, making it easier ...
Is there a free call blocking app that actually works? I ...Wide Protect - an excellent call blocking app that is easy-to-use that doesn't collect any personalized data. Should I Answer? is a great pick ...
6.hiya.comhiya.com/
Stop spam calls & display caller ID, with Hiya's AI voice platformThe Hiya AI Phone app blocks spam, takes call notes, generates summaries and keeps you organized — so you can focus on what matters.
Hiya: Spam Blocker & Caller ID - App StoreHiya blocks spam and scam calls, and displays caller ID name and call reason on incoming calls. Want to supercharge your Hiya app? Try our Premium features.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security